Epoxomicin Sensitizes Resistant Osteosarcoma Cells to TRAIL Induced Apoptosis.
Hanikoglu F, Cort A, Ozben H, Hanikoglu A, Ozben T.
Anticancer Agents Med Chem · research support, non-u.s. gov't; journal article · DOI 10.2174/1871520615666150209111650 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för epoxomicin. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
5 hitsThe influence of epoxomicin, inhibitor of proteasomal proteolytic activity, on spermiogenesis in Chara vulgaris.
Kwiatkowska M, Wojtczak A, Popłońska K, Teodorczyk M.
Folia Histochem Cytobiol · comparative study; research support, non-u.s. gov't; journal articleThe selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M.
J Immunol · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.4049/jimmunol.164.12.6147Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity.
Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM.
Proc Natl Acad Sci U S A · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1073/pnas.96.18.10403Epoxomicin, a new antitumor agent of microbial origin.
Hanada M, Sugawara K, Kaneta K, Toda S, Nishiyama Y, Tomita K, Yamamoto H, Konishi M, Oki T.
J Antibiot (Tokyo) · comparative study; journal article · DOI 10.7164/antibiotics.45.1746